1,043 results on '"Martini, Maurizio"'
Search Results
2. Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer
3. Retzius-sparing vs. standard robot-assisted radical prostatectomy for clinically localised prostate cancer: a comparative study
4. Sarco/endoplasmic reticulum calcium ATPase 3 (SERCA3) expression in gastrointestinal stromal tumours
5. PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores
6. CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer
7. Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey
8. The minefield of indeterminate thyroid nodules: could artificial intelligence be a suitable diagnostic tool?
9. Systemic ALK-negative anaplastic large cell lymphoma with distinctive myxoid change and DUSP22 rearrangement
10. A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP and implications for training
11. Aggressive variants of follicular cell-derived thyroid carcinoma: an overview
12. Rare histotypes of epithelial biliary tract tumors: A literature review
13. SAT-378 Association between occult hepatitis B virus infection and parenchymal renal cell carcinoma
14. Role of IL-33/ST2 Pathway in Inflammatory Bowel Disease: An Overview and Future Perspectives
15. Role of Multiparametric Magnetic Resonance Imaging and Targeted Biopsy in the Detection of Clinically Significant Prostate Cancer in Patients with Suspicious Digital Rectal Examination
16. The Morphology of Nasal Polyps in Different Age Groups: Histopathological Features
17. The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder Cancer
18. Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer
19. Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma
20. Clinical and Molecular Features in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinosis from Colorectal Cancer
21. FMRP modulates the Wnt signalling pathway in glioblastoma
22. Digital Pathology Applications for PD-L1 Scoring in Head and Neck Squamous Cell Carcinoma: A Challenging Series
23. Pilocytic astrocytoma: The paradigmatic entity in low‑grade gliomas (Review)
24. PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors
25. Correction to: Systemic ALK-negative anaplastic large cell lymphoma with distinctive myxoid change and DUSP22 rearrangement
26. Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets
27. Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process
28. Programmed Cell Death Ligand 1 (PD-L1) Immunohistochemical Expression in Advanced Urothelial Bladder Carcinoma: An Updated Review with Clinical and Pathological Implications.
29. La moda della vacanza: Luoghi e storie 1860-1939
30. DDX3X inhibitors, an effective way to overcome HIV-1 resistance targeting host proteins
31. The Role of Checkpoint Inhibitor Expression Directly on Exfoliated Cells from Bladder Cancer: A Narrative Review
32. Clear cell endometrial carcinoma precursors: presentation of two cases and diagnostic issues
33. ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism
34. IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation
35. Elesclomol-induced increase of mitochondrial reactive oxygen species impairs glioblastoma stem-like cell survival and tumor growth
36. PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders
37. A review of the cytomorphological features of NIFTP
38. Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes
39. Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples
40. Unusual localization and clinical presentation of primary central nervous system extranodal marginal zone B‑cell lymphoma: A case report
41. First-line ICIs in renal cell carcinoma
42. OMICS AND PROGNSTIC MARKERS
43. Endothelial trans-differentiation in glioblastoma recurring after radiotherapy
44. Plexiform architecture in gastrointestinal stromal tumors is not restricted to succinate dehydrogenase-deficient cases
45. Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma
46. Erlotinib for Patients with EGFR Wild-Type Metastatic NSCLC: a Retrospective Biomarkers Analysis
47. Molecular Testing in EBUS-TBNA Specimens of Lung Adenocarcinoma: A Study of Concordance Between Cell Block Method and Liquid-Based Cytology in Appraising Sample Cellularity and EGFR Mutations
48. Eight-year survival of a recurrent glioblastoma patient treated with molecularly tailored therapy: a case report
49. Bleeding “sarcomatosis” as a rare presentation of vascular graft-related angiosarcoma: case report and review of the literature
50. Autophagic-Related Proteins in Brain Gliomas: Role, Mechanisms, and Targeting Agents
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.